HUMA
Humacyte, Inc. · Healthcare
Director and 10% owner Brady W Dougan sold $6.1M of Humacyte, Inc.
Sold$6,090,000
$4.00Price
1,522,500Shares
−7%Stake
What HUMA did after the filing
- The stock from Tue, Sep 20 open, $3.85
- −6.0%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Nov 1 close.
Traded Thu, Sep 15. Filed Mon, Sep 19. Returns use the Sep 20 open and the Nov 1 close. Not investment advice.